361 related articles for article (PubMed ID: 17929272)
1. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
[TBL] [Abstract][Full Text] [Related]
2. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.
Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX
Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627
[TBL] [Abstract][Full Text] [Related]
3. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade.
Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R
Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708
[TBL] [Abstract][Full Text] [Related]
5. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.
Su SL; Huang IP; Fair WR; Powell CT; Heston WD
Cancer Res; 1995 Apr; 55(7):1441-3. PubMed ID: 7882349
[TBL] [Abstract][Full Text] [Related]
6. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.
Ross JS; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Webb I; Gray GS; Mosher R; Kallakury BV
Clin Cancer Res; 2003 Dec; 9(17):6357-62. PubMed ID: 14695135
[TBL] [Abstract][Full Text] [Related]
7. Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis.
Zhang L; Wang CY; Yang R; Shi J; Fu R; Chen L; Klocker H; Zhang J
Urol Oncol; 2008; 26(6):634-40. PubMed ID: 18367130
[TBL] [Abstract][Full Text] [Related]
8. Expression of the prostate-specific membrane antigen.
Israeli RS; Powell CT; Corr JG; Fair WR; Heston WD
Cancer Res; 1994 Apr; 54(7):1807-11. PubMed ID: 7511053
[TBL] [Abstract][Full Text] [Related]
9. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific membrane antigen and its truncated form PSM'.
Mlcochová P; Barinka C; Tykvart J; Sácha P; Konvalinka J
Prostate; 2009 Apr; 69(5):471-9. PubMed ID: 19107881
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.
O'Keefe DS; Bacich DJ; Heston WD
Prostate; 2004 Feb; 58(2):200-10. PubMed ID: 14716746
[TBL] [Abstract][Full Text] [Related]
12. [The construction of recombinant plasmid with prostate-specific membrane antigen promoter controlling reporter gene expression].
Zeng H; Li H; Liao YC; Li X; Wu Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):169-71. PubMed ID: 15807257
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.
Kawakami M; Nakayama J
Cancer Res; 1997 Jun; 57(12):2321-4. PubMed ID: 9192800
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prostate-specific membrane antigen splice variants in LNCap cells.
Williams T; Kole R
Oligonucleotides; 2006; 16(2):186-95. PubMed ID: 16764542
[TBL] [Abstract][Full Text] [Related]
16. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
Ben Jemaa A; Sallami S; Céraline J; Oueslati R
Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
[TBL] [Abstract][Full Text] [Related]
17. The use of real-time quantitative PCR to detect circulating prostate-specific membrane antigen mRNA in patients with prostate carcinoma.
Chu DC; Chuang CK; Liou YF; Tzou RD; Lee HC; Sun CF
Ann N Y Acad Sci; 2004 Jun; 1022():157-62. PubMed ID: 15251956
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
[TBL] [Abstract][Full Text] [Related]
20. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage.
Grasso YZ; Gupta MK; Levin HS; Zippe CD; Klein EA
Cancer Res; 1998 Apr; 58(7):1456-9. PubMed ID: 9537248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
